Press Release Summary:
Made of soft and breathable fabric, eye mask has pocket on each side that holds crescent shaped ActiPatch to assure proper placement of therapy over each eye after blepharoplasty surgery. Design allows patient to continue their normal activities during daytime treatment. At night, patient can then move mask over eyes to receive treatment on both upper and lower lids while sleeping.
Original Press Release:
BioElectronics Corporation Introduces Its New Eye Surgery Recovery Mask
FREDERICK, Md., April 27 -- BioElectronics Corporation, (BIEL), announces that its specially designed eye mask for placement of ActiPatch Therapy after blepharoplasty surgery is now available. The mask, made of a soft and comfortable breathable fabric has a pocket on each side that holds a crescent shaped ActiPatch to assure proper placement of therapy over each eye. The unique design allows a patient to continue their normal activities during daytime treatment. At night, the patient can then move the mask over the eyes to receive treatment on both the upper and lower lids while sleeping.
"We believe that providing a simple way to place the therapy in the desired area without the use of adhesive will simplify post surgical care for both the patient and the recovery staff, said Lauren Jarman. Ms. Jarman is the designer of the mask.
The Company has also recently introduced new products including a head band for face lift healing therapy, a breast wrap, and a multi purpose wrap for pharmacy sales.
ActiPatch has been clinically proven to reduce swelling and bruising up to 50%. Plastic surgeons who are currently using ActiPatch have noted that in addition to their patients healing faster, the need for pain medication has been drastically reduced.
ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling.
For more information visit http://www.bioelectronicscorp.com/.
Source: BioElectronics Corporation
Andrew J. Whelan,
President & CEO of BioElectronics Corporation,